| 临床病理特征 | 胰腺癌伴糖尿病组 (n = 125) | 胰腺癌不伴糖尿病组 (n = 134) | P值 |
| 年龄 | 64 (56, 70) | 63 (55, 69) | 0.300 |
| 性别 |
|
| 0.048 |
| 男性 | 72 (57.6%) | 93 (69.4%) |
|
| 女性 | 53 (42.4%) | 41 (30.6%) |
|
| BMI (kg/m2) | 23.8 ± 3.2 | 22.7 ± 3.2 | 0.010 |
| 吸烟 | 29 (23.2%) | 46 (34.3%) | 0.048 |
| 饮酒 | 23 (18.5%) | 28 (20.9%) | 0.956 |
| 肿瘤位置 |
|
| 0.503 |
| 胰头 | 79 (63.2%) | 90 (67.2%) |
|
| 胰体尾 | 46 (36.8%) | 44 (32.8%) |
|
| 肿瘤大小 |
|
| 0.315 |
| ≤2 cm | 11 (8.8%) | 6 (4.5%) |
|
| >2 cm且≤4 cm | 84 (67.2%) | 90 (67.2%) |
|
| >4 cm | 30 (24.0%) | 38 (28.4%) |
|
| 分化程度 |
|
| 0.082 |
| 低分化 | 23 (18.4%) | 31 (23.1%) |
|
| 中低分化 | 19 (15.2%) | 28 (20.9%) |
|
| 中分化 | 79 (63.2%) | 75 (56.0%) |
|
| 高分化 | 4 (3.2%) | 0 (0%) |
|
| TNM分期 |
|
| 0.409 |
| I期 | 43 (34.4%) | 40 (29.9%) |
|
| II期 | 36 (28.8%) | 52 (38.8%) |
|
| III期 | 25 (20.0%) | 23 (17.2%) |
|
| IV期 | 21 (16.8%) | 19 (14.2%) |
|